Fresenius Medical Care AG

FME: XETR (DEU)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
^LLOCK|N@&yPLOCK|#pk^cKc

Fresenius Medical Care Earnings: Solid Trends Put It on Target to Meet 2025 Expectations

In constant currency in the second quarter, Fresenius Medical Care generated 7% organic revenue growth, adjusted operating income growth of 13%, and adjusted EPS growth of 30% including lower interest, tax, and minority interest expenses. Management also confirmed their guidance for 2025.

Sponsor Center